Perrigo (NYSE:PRGO – Get Rating) issued an update on its FY 2022 earnings guidance on Wednesday morning. The company provided EPS guidance of $2.30-$2.40 for the period. The company issued revenue guidance of $4.49 billion-$4.53 billion, compared to the consensus revenue estimate of $4.49 billion.
Separately, StockNews.com started coverage on shares of Perrigo in a report on Thursday, March 31st. They issued a hold rating for the company.
Shares of Perrigo stock opened at $36.77 on Friday. The stock has a market capitalization of $4.95 billion, a P/E ratio of -56.57 and a beta of 1.02. The company has a quick ratio of 1.79, a current ratio of 4.01 and a debt-to-equity ratio of 0.69. The company has a 50-day simple moving average of $36.05 and a 200 day simple moving average of $38.09. Perrigo has a 12-month low of $31.32 and a 12-month high of $50.90.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 21st. Investors of record on Friday, June 3rd will be given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 2.83%. The ex-dividend date of this dividend is Thursday, June 2nd. Perrigo’s dividend payout ratio (DPR) is currently -160.00%.
In other Perrigo news, EVP Thomas Farrington sold 24,485 shares of the firm’s stock in a transaction dated Monday, March 14th. The shares were sold at an average price of $37.13, for a total value of $909,128.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Ronald Craig Janish sold 3,954 shares of the firm’s stock in a transaction dated Monday, March 7th. The shares were sold at an average price of $36.73, for a total transaction of $145,230.42. The disclosure for this sale can be found here. Company insiders own 0.80% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of PRGO. Arrowstreet Capital Limited Partnership bought a new position in shares of Perrigo in the 1st quarter valued at about $24,684,000. BlackRock Inc. boosted its stake in shares of Perrigo by 4.8% in the 1st quarter. BlackRock Inc. now owns 12,112,154 shares of the company’s stock valued at $465,469,000 after purchasing an additional 554,915 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Perrigo by 2,841.8% during the 1st quarter. Renaissance Technologies LLC now owns 444,208 shares of the company’s stock worth $17,071,000 after acquiring an additional 429,108 shares during the last quarter. Morgan Stanley boosted its stake in Perrigo by 68.1% during the 2nd quarter. Morgan Stanley now owns 759,459 shares of the company’s stock worth $34,822,000 after acquiring an additional 307,689 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in Perrigo by 8.4% during the 1st quarter. Northern Trust Corp now owns 1,402,872 shares of the company’s stock worth $53,913,000 after acquiring an additional 109,204 shares during the last quarter. 91.25% of the stock is currently owned by institutional investors.
About Perrigo (Get Rating)
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International.
- Get a free copy of the StockNews.com research report on Perrigo (PRGO)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.